No, platelet transfusions may exacerbate the thrombotic tendency in HIT. Platelet transfusion should be reserved for patients with active bleeding or at high risk of bleeding.…
It may be considered once the platelet count increases to a safe level (e.g., > 50 x 109/L), but there is no evidence of clinical efficacy…
Caplacizumab does not affect ADAMTS levels or ADAMTS13 antibody production. It is an anti–von Willebrand factor humanized, bivalent variable-domain-only immunoglobulin fragment that inhibits interaction between von…
375 mg/m2 IV weekly for 4 weeks.
2019 Guidelines on the Use of Therapeutic Apheresis in Clinical Practice: [Plasma exchange] is generally performed daily until the platelet count is >150 × 109/L, and…
Based on a landmark randomized study in 1991 (see abstract below), plasma exchange was reported to be associated with a mortality rate of about 10%, vs.…
Removes autoantibodies and replenishes ADAMTS13 levels.